[The use of L-asparaginase in the treatment of acute lymphoblastic leukemia in childhood].
D001215:Asparaginase / Q000008:administration & dosage* / Q000009:adverse effects; D001663:Bilirubin / Q000032:analysis; D001792:Blood Platelets / Q000187:drug effects; D001798:Blood Proteins / Q000032:analysis; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D007962:Leukocytes / Q000187:drug effects; D008297:Male; D010744:Phosphoric Monoester Hydrolases / Q000097:blood; D000637:Transaminases / Q000097:blood
D001798:Blood Proteins; D000637:Transaminases; D010744:Phosphoric Monoester Hydrolases; D001215:Asparaginase; D001663:Bilirubin
L'impiego della L-asparaginasi nel trattamento della leucemia linfoblastica acuta nell'infanzia.